Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

Share Price is delayed by 15 minutes
Get Live Data
1,859.00    42.00 (2.31%)
Bid:
1,856.00
Ask:
1,858.00
Spread: 2.00 (0.108%)
Market Cap: £2.08b
DLN Live PriceLast checked at - London Stock Exchange

Intraday Derwent London Share Chart

Lettings update

24 Apr 2015 08:00

RNS Number : 1958L
Derwent London PLC
24 April 2015
 



 

 

 

24 April 2015

Derwent London plc ("Derwent London" / "the Group")

DERWENT LONDON SECURES OVER £3M OF ADDITIONAL RENT TAKINGNEW LETTINGS TO £10.6M SO FAR IN 2015

Derwent London has secured £10.6m pa of rents from new lettings in the year to date, which already exceeds the £9.2m we achieved in the whole of 2014. Recent transactions total more than £3m pa, with the principal ones shown below.

 

At the recently acquired Angel Square, Islington EC1 the Group has let 40,700 sq ft of offices in Block Two to The Office Group, the flexible office space provider. The occupier is taking a 10-year lease with a landlord's break from year five at a base rent of £1.4m pa, reflecting £35 per sq ft. The incentives are equivalent to a nine-month rent free period. The Group will receive a share of The Office Group's profits above a minimum level. Angel Square is a 128,700 sq ft office property acquired in November 2014. The passing rent at acquisition was £2.4m pa, but the majority of the leases expired in March 2015. In the last two months we have re-let over 75% of the building, and renewed one lease for a combined income of £3.7m pa. This newly let income alone represents a 54% increase on the property's income at the time of acquisition, and the Group will refurbish the 25,000 sq ft balance of the property upon vacant possession.

 

At the Davidson Building, Covent Garden WC2, where four floors totalling 23,200 sq ft have recently been refurbished, the Group has let 10,600 sq ft to two occupiers on 10-year leases with breaks in year five. The combined rent is £0.8m pa equating to £80 per sq ft on the terraced penthouse fifth floor (4,370 sq ft) and £72.50 per sq ft on the fourth floor (6,230 sq ft). Both leases have minimum rental uplifts in year five. There is a further 12,600 sq ft available at this property.

 

At the Tea Building, Shoreditch E1, a rent of £47.50 per sq ft (£0.4m pa) was attained after Feed, an independent communications agency, took just under 8,000 sq ft on a five-year lease. This exceeded the previous high of £39 per sq ft which was achieved last year.

 

At Morelands, Clerkenwell EC1, existing tenant Spark44, a marketing and communications agency, has taken further space at a rent of £55 per sq ft or £0.3m pa, with a minimum uplift to £60 per sq ft on first review, on a 5,370 sq ft unit for nine years with a tenant's break at five years.

 

John Burns, Chief Executive Officer of Derwent London, commented:

 

"These recent deals are further confirmation of the continuing strength of the central London letting market that we reported with our results in February. We are delighted that we have achieved our initial plans for Angel Square so quickly."

 

 

For further information, please contact:

 

Derwent London

Tel: +44 (0)20 7659 3000

 

 

John Burns, Chief Executive Officer

Celine Thompson, Head of Leasing

Quentin Freeman, Head of Investor Relations

Brunswick Group

Tel: +44 (0)20 7404 5959

Simon Sporborg

Nina Coad

 

 

 

 

 

 

 

 

Notes to editors

 

Derwent London plc

Derwent London plc owns a portfolio of commercial real estate predominantly in central London valued at £4.2 billion as at 31 December 2014, making it the largest London-focused real estate investment trust (REIT).

Our experienced team has a long track record of creating value throughout the property cycle by regenerating our buildings via development or refurbishment, effective asset management and capital recycling.

We typically acquire central London properties off-market with low capital values and modest rents in improving locations, most of which are either in the West End or the Tech Belt. We capitalise on the unique qualities of each of our properties - taking a fresh approach to the regeneration of every building with a focus on anticipating tenant requirements and an emphasis on design.

Reflecting and supporting our long-term success, the business has a strong balance sheet with modest leverage, a robust income stream and flexible financing.

Landmark schemes in our portfolio of 5.7 million sq ft as at 31 December 2014 include Angel Building EC1, The Buckley Building EC1, White Collar Factory EC1, 1-2 Stephen Street W1, Horseferry House SW1 and Tea Building E1.

In December 2014 Derwent London topped the real estate sector for the fifth year in a row and was placed ninth overall in the Management Today awards for 'Britain's Most Admired Companies'. Also in 2014 the Group won the Property Week 'Developer of the Year' and the RICS London Commercial Award, and was shortlisted for awards by Architects' Journal, BCO, NLA and OAS. The Group was also awarded EPRA Gold for corporate and sustainability reporting.

For further information see www.derwentlondon.com or follow us on Twitter at @derwentlondon

 

Forward-looking statements

This document contains certain forward-looking statements about the future outlook of Derwent London. By their nature, any statements about future outlook involve risk and uncertainty because they relate to events and depend on circumstances that may or may not occur in the future. Actual results, performance or outcomes may differ materially from any results, performance or outcomes expressed or implied by such forward-looking statements.

No representation or warranty is given in relation to any forward-looking statements made by Derwent London, including as to their completeness or accuracy. Derwent London does not undertake to update any forward-looking statements whether as a result of new information, future events or otherwise. Nothing in this announcement should be construed as a profit forecast.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSELFWDFISEEL
Date   Source Headline
12th Aug 20257:00 amRNSBoard Change
12th Aug 20257:00 amRNSInterim Results
5th Aug 20257:00 amRNSNew headlease agreed at 50 Baker Street W1
31st Jul 20254:45 pmRNSTotal Voting Rights
29th Jul 20257:00 amRNSDisposal of Francis House SW1 for £55.5m
25th Jul 20257:00 amRNSExtension of £450m Revolving Credit Facility
30th Jun 20254:45 pmRNSTotal Voting Rights
18th Jun 20257:00 amRNSAdobe lease extension and expansion
12th Jun 202511:00 amRNSRedemption of £175 million Convertible Bonds
30th May 20254:45 pmRNSTotal Voting Rights
29th May 202511:15 amRNSHolding(s) in Company
23rd May 20254:05 pmRNS£250m 7-year 5.25% bond issuance
16th May 202512:00 pmRNSResults of 2025 Annual General Meeting
8th May 20257:00 amRNSFirst Quarter Business Update
1st May 202510:00 amRNSAnnual Bondholder Meeting
30th Apr 20254:45 pmRNSTotal Voting Rights
15th Apr 202510:00 amRNSAnnual Financial Report
9th Apr 20253:00 pmRNSAdditional Listing
31st Mar 20254:45 pmRNSTotal Voting Rights
31st Mar 202510:00 amRNSNotice of Q1 2025 Business Update
26th Mar 20251:00 pmRNSDirector/PDMR Shareholding
20th Mar 20254:45 pmRNSBlock listing Interim Review
7th Mar 20252:00 pmRNSDirector/PDMR Shareholding
4th Mar 20255:15 pmRNSDirector/PDMR Shareholding
28th Feb 20254:45 pmRNSTotal Voting Rights
27th Feb 20257:00 amRNSResults for the Year Ended 31 December 2024
31st Jan 20254:45 pmRNSTotal Voting Rights
30th Jan 20255:35 pmRNSHolding(s) in Company
27th Jan 20251:30 pmRNSHolding(s) in Company
9th Jan 20257:00 amRNS25 Baker Street W1 offices fully pre-let
31st Dec 202412:45 pmRNSTotal Voting Rights
3rd Dec 20247:00 amRNSAcquisition
29th Nov 20244:45 pmRNSTotal Voting Rights
7th Nov 20247:00 amRNSTHIRD QUARTER BUSINESS UPDATE
5th Nov 202412:44 pmRNSHolding(s) in Company
31st Oct 20244:45 pmRNSTotal Voting Rights
23rd Oct 20245:30 pmRNSHolding(s) in Company
16th Oct 202410:30 amRNSDirectorate Change
30th Sep 20244:45 pmRNSTotal Voting Rights
20th Sep 20244:45 pmRNSBlock listing Interim Review
19th Sep 202411:00 amRNSDirector/PDMR Shareholding
17th Sep 202411:03 amRNSHolding(s) in Company
30th Aug 20244:45 pmRNSTotal Voting Rights
23rd Aug 202411:15 amRNSAdditional Listing
8th Aug 20247:00 amRNSHalf-Year Results
31st Jul 20244:45 pmRNSTotal Voting Rights
28th Jun 20244:45 pmRNSTotal Voting Rights
12th Jun 202411:00 amRNSHolding(s) in Company
10th Jun 20244:00 pmRNSDirector/PDMR Shareholding
31st May 20244:45 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.